Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03690986
Title VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

oropharynx cancer

head and neck squamous cell carcinoma

Therapies

Ipilimumab

Nivolumab

Ipilimumab + Pepinemab

Nivolumab + Pepinemab

Pepinemab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.